Company

Sanofi Reports 3.3% YOY Sales Growth in Q2 2023, Driven by Vaccines and Dupixent

CompanyDrug

Huadong Medicine Receives NMPA Approval for Phase I Clinical Trial of DR10624 for Weight Management

Policy / Regulatory

NMPA Seeks Public Input on Strengthening Supervision of Medical Device Contract Manufacturing

Policy / Regulatory

China’s NHC Launches Trial Specifications for Clinical Decision Support Systems in Hospitals

CompanyDrug

Yingli Pharma’s YL-17231 Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors

Policy / Regulatory

NHSA Issues 2023 Guidelines: Enhancing Basic Medical Insurance and Major Illness Coverage

CompanyDrug

Akeso Biopharma Initiates Phase Ia/Ib Study for TIGIT mAb AK127 in Solid Tumors Combination Therapy

CompanyDeals

ACROBiosystems Partners with OBiO Technology to Advance Cell and Gene Therapy

CompanyDeals

Lucence and Innovent Biologics Partner to Enhance Access to Cholangiocarcinoma Treatment in Hong Kong

CompanyMedical Device

Beijing Balance Medical’s Transcatheter Valve System Enters China’s Innovative Device Review

CompanyDrug

Eli Lilly’s Tirzepatide Demonstrates Up to 26.6% Weight Loss in Phase III Obesity Studies

Policy / Regulatory

CDE Issues Guiding Principles for Natural History Research in Rare Disease Drug Development